High Prevalence of SOD1 Pathogenic Variants in the UK Biobank: Implications for Early Intervention in Amyotrophic Lateral Sclerosis

March 19, 2026Annals of NeurologyOpen Access

View Full Paper

Ask AI

Bookmark

Share

Key Points

This research investigates the prevalence of SOD1 pathogenic variants in the UK Biobank and their implications for early intervention in amyotrophic lateral sclerosis (ALS).
Analyzed genetic data from the UK Biobank
Assessed age-related penetrance and phenoconversion risk
Identified biological indicators influencing disease progression
High prevalence of SOD1 pathogenic variants detected in the UK Biobank cohort
Underascertainment due to disease heterogeneity was noted
Need for improved identification of genetic and environmental risk factors established

Answers are grounded in this paper and cite their sources.

Research reports high prevalence of SOD1 variants in the UK Biobank, indicating needs for early intervention in ALS.

No abstract yet. The journal hasn't published one we can show.

No takes yet. Share an insight, caveat, or question.

Gagliardi et al. (2026) studied this question.

View Full Paper

Ask AI

Bookmark

Share